Literature DB >> 8170289

Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors.

P C Dagnelie1, J D Bell, S C Williams, T E Bates, P D Abel, C S Foster.   

Abstract

The aim of this study was to investigate whether tumor-induced cachexia and aberrations in host liver metabolism, induced by the MAT-LyLu variant of the Dunning prostate tumor, could be prevented by omega 3 fatty acids from fish oil. On day 0, adult Copenhagen-Fisher rats fed normal chow ad libitum were inoculated with 10(6) MAT-LyLu cells (n = 14) or saline (n = 9). On day 7, when tumors were palpable, four tumor-bearing (TB) and four nontumor-bearing (NTB) rats were put on isocaloric diets with 50% of total energy as fish oil. The introduction of fish oil-enriched diets caused a reduction in energy intake to less than half of the energy intake by animals fed normal diets during days 7-14 (difference by dietary group: NTB, P < 0.001; TB, P < 0.001). During days 14-21, energy intake in fish oil-fed animals returned to approximately 75% of energy intake by animals fed normal diets (difference by dietary group: NTB, P < 0.003; TB, P = 0.001). Carcass weight of animals on day 21, when the study was terminated, was significantly related to initial weight (P = 0.05) and mean food intake during the study (P = 0.01). When data were adjusted for these variables using analysis of covariance, with NTB animals on normal diets being the reference group, significant loss of carcass weight was observed in TB animals on normal diets only (mean +/- SEM 58 +/- 10 g loss, P < 0.001), but not in TB animals on fish oil diets (8 +/- 18 g loss, P = 0.67).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170289     DOI: 10.1007/bf02536729

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Cell-surface oligosaccharides expressed by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer.

Authors:  I Bashir; K Sikora; C S Foster
Journal:  Biochem Soc Trans       Date:  1990-10       Impact factor: 5.407

Review 2.  Omega 3 fatty acids and cancer metastasis in humans.

Authors:  J Man-Fan Wan; B S Kanders; M Kowalchuk; H Knapp; D J Szeluga; J Bagley; G L Blackburn
Journal:  World Rev Nutr Diet       Date:  1991       Impact factor: 0.575

Review 3.  Dietary omega 3 fatty acids and cancer: an overview.

Authors:  C Galli; R Butrum
Journal:  World Rev Nutr Diet       Date:  1991       Impact factor: 0.575

4.  Phosphodiesters in the liver: the effect of field strength on the 31P signal.

Authors:  T E Bates; S R Williams; D G Gadian
Journal:  Magn Reson Med       Date:  1989-10       Impact factor: 4.668

5.  Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes.

Authors:  C E Borgeson; L Pardini; R S Pardini; R C Reitz
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

6.  Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid.

Authors:  M J Tisdale; S A Beck
Journal:  Biochem Pharmacol       Date:  1991-01-01       Impact factor: 5.858

Review 7.  Omega-3 fatty acids in health and disease and in growth and development.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

8.  Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.

Authors:  M C Bibby; J A Double; S A Ali; K C Fearon; R A Brennan; M J Tisdale
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

9.  Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.

Authors:  I J Cox; D K Menon; J Sargentoni; D J Bryant; A G Collins; G A Coutts; R A Iles; J D Bell; I S Benjamin; S Gilbey
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

10.  Altered phosphorylation status, phospholipid metabolism and gluconeogenesis in the host liver of rats with prostate cancer: a 31P magnetic resonance spectroscopy study.

Authors:  P C Dagnelie; J D Bell; S C Williams; T E Bates; P D Abel; C S Foster
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  7 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 2.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

3.  Modifications in mitochondrial metabolism and ultrastructure and their relationship to tumour growth inhibition by gamma-linolenic acid.

Authors:  A Colquhoun; R I Schumacher
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

4.  A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.

Authors:  Elaine S Rogers; Roderick D MacLeod; Joanna Stewart; Stephen P Bird; Justin W L Keogh
Journal:  BMC Cancer       Date:  2011-11-23       Impact factor: 4.430

Review 5.  Diet composition as a source of variation in experimental animal models of cancer cachexia.

Authors:  Kaitlin Giles; Chen Guan; Thomas R Jagoe; Vera Mazurak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-15       Impact factor: 12.910

Review 6.  Hypothalamic integration of immune function and metabolism.

Authors:  Ana Guijarro; Alessandro Laviano; Michael M Meguid
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

Review 7.  Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models.

Authors:  Wouter R P H van de Worp; Annemie M W J Schols; Jan Theys; Ardy van Helvoort; Ramon C J Langen
Journal:  Front Nutr       Date:  2020-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.